HEPATOBILIARY ELIMINATION OF BENDAMUSTIN (CYTOSTASAN) IN RATS

被引:0
作者
BEZEK, S [1 ]
SCASNAR, V [1 ]
TRNOVEC, T [1 ]
GRUPE, R [1 ]
机构
[1] INST PHARMACOL RES, BERLIN, GERMANY
来源
PHARMAZIE | 1991年 / 46卷 / 11期
关键词
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Biliary excretion of bendamustin (Cytostasan(R), 5-[bis (2-chloroethyl)amino]-i-methylbenzimidazole-2-butyric acid; 1) and its metabolites was studied in rats after i.v. administration of C-14-1. The most significant finding was the rapid excretion of 1 related radioactivity in the bile occurring shortly after injection. While radioactivity eliminated by bile within 2 h was 41.8%, in the course of subsequent 22 h it amounted only to 3.2%. Bile samples analyzed by TLC indicated that the total amount of radioactivity was excreted in the form of conjugates and two hydroxy metabolites. A significant amount of radioactivity was excreted in urine. The diversion of bile by cannulation of the bile duct led to a significant decrease of elimination by feces.
引用
收藏
页码:810 / 811
页数:2
相关论文
共 8 条
[1]   BILIARY-EXCRETION OF MELPHALAN BY CONTROL AND ANURIC RATS [J].
BYINGTON, KH ;
BOWIE, CC ;
MCKINSEY, DS .
BIOCHEMICAL PHARMACOLOGY, 1980, 29 (18) :2518-2520
[2]  
HESS G, 1971, ZENTBL PHARM PHARMAK, V110, P1086
[3]   HYDROLYSIS OF GAMMA-[1-METHYL-5-BIS(BETA-CHLOROETHYL)AMINO-2-BENZIMIDAZOLYL]BUTYRIC ACID STUDIED BY H-1-NMR [J].
KLOSE, G ;
AUGSTEN, K ;
BARTH, A ;
SAMEK, Z .
ORGANIC MAGNETIC RESONANCE, 1982, 19 (01) :15-20
[4]  
PREISS R, 1985, PHARMAZIE, V40, P782
[5]   RADIOCHEMICAL ASSAY OF STABILITY OF C-14 CYTOSTASAN SOLUTIONS DURING PREPARATION AND STORAGE [J].
SCASNAR, V ;
BEZEK, S ;
TRNOVEC, T ;
GRUPE, R ;
LISSE, I .
JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY-ARTICLES, 1988, 121 (02) :489-497
[6]   EXCRETION OF CYCLOPHOSPHAMIDE METABOLITES IN BILE [J].
SHAW, IC ;
GRAHAM, MI .
BIOCHEMICAL PHARMACOLOGY, 1984, 33 (15) :2535-2538
[7]  
SWEATMAN TW, 1987, CANCER CHEMOTH PHARM, V19, P201
[8]  
WERNER W, 1987, PHARMAZIE, V42, P272